腹腔镜子宫肌瘤切除术围手术期应用抗菌药物的情况回顾性分析

doi:10.3969/j.issn.1000-8535.2022.04.012

摘要/Abstract

摘要： 目的对腹腔镜子宫肌瘤切除术围手术期应用抗菌药物的情况进行回顾性分析,并分析腹腔镜子宫肌瘤切除术围手术期感染的影响因素。方法选择2018年5月—2021年5月在我院行腹腔镜子宫肌瘤切除术的患者72例进行回顾性分析。收集患者一般资料及抗生素使用情况,根据有无术后感染将患者分为2组,比较2组患者上述各资料,并采用多因素分析法判断各因素对腹腔镜子宫肌瘤切除术后感染的综合作用。结果本次纳入的72例腹腔镜子宫肌瘤切除术患者共有16例出现术后感染,术后感染率为22.22%。多因素Logistic回归分析结果显示:年龄≥50岁、手术时间≥60 min、合并糖尿病为腹腔镜子宫肌瘤切除术围手术期感染的危险因素,预防性使用抗生素、术前≤2 h抗生素使用、术后抗生素使用≤48 h为保护性因素(P<0.05)。结论腔镜子宫肌瘤切除术患者术后感染率为22.22%,抗菌药物使用时机及使用时间对腹腔镜子宫肌瘤切除术患者术后感染有重要的影响,此外患者年龄、手术时间、合并糖尿病情况也与患者术后感染有关。

关键词: 腹腔镜, 子宫肌瘤, 术后感染, 抗菌药物, 多因素分析

Abstract: Objective To retrospectively analyze the perioperative application of antibacterial drugs during laparoscopic myomectomy, and to analyze the influencing factors of infection during the perioperative period of laparoscopic myomectomy. Methods Seventy-two patients who underwent laparoscopic myomectomy in our hospital from May 2018 to May 2021 were selected for retrospective analysis. The patients were divided into two groups according to postoperative infection status. The above data were compared between the two groups, and the comprehensive effects of various factors on postoperative infection after laparoscopic myomectomy were determined by multivariate analysis. Results There were 16 cases of 72 patients underwent laparoscopic myomectomy had postoperative infection, and the postoperative infection rate was 22.22%. Multivariate Logistic regression analysis showed that age over 50, operation time over 60 minutes, and with diabetes mellitus were the risk factors of perioperative infection in laparoscopic myomectomy. Prophylactic use of antibiotics, preoperative use of antibiotics in less than 2 hours and postoperative use of antibiotics in less than 48 hours were protective factors (P<0.05). Conclusions The infection rate of patients underwent laparoscopic myomectomy was 22.22%. The time and length of antibiotics use had important influence on postoperative infection of patients underwent laparoscopic myomectomy. In addition, age, operation time and complicated with diabetes mellitus were also related to postoperative infection.

Key words: laparoscopy, uterine fibroids, postoperative infection, antibacterial drugs, multivariate analysis

陈月月, 张梦真, 沈玲, 李展展. 腹腔镜子宫肌瘤切除术围手术期应用抗菌药物的情况回顾性分析[J]. 广州医药, 2022, 53(4): 51-55.

CHEN Yueyue, ZHANG Mengzhen, SHEN Ling, LI Zhanzhan. Retrospective analysis of the perioperative application of antibacterial drugs during laparoscopic myomectomy[J]. Guangzhou Medical Journal, 2022, 53(4): 51-55.

参考文献

[1] 史莎莎, 余成浩. 子宫肌瘤的治疗进展[J]. 中国妇幼保健, 2020, 35(16):192-195.
[2] LEE J, GERBER D, APHINYANAPHONGS Y, et al. Laparoscopy decreases the disparity in postoperative complications between black and white women after hysterectomy for endometrial cancer[J]. Gynecol Oncol, 2018, 149(1): 22-27.
[3] 江莉. 腹腔镜子宫肌瘤剔除术治疗子宫肌瘤患者临床效果及术后并发症观察[J]. 中国妇幼保健, 2018, 33(19):4531-4533.
[4] 陈凤. 腹腔镜子宫肌瘤剔除术对子宫肌瘤患者并发症发生率的影响[J]. 中国数字医学, 2020, 15(3):118-119,125.
[5] 梁立梅, 杨凤娟, 张昆,等. 子宫肌瘤剔除术前应用抗菌药物对血清炎性因子及术后切口感染的影响[J]. 中华医院感染学杂志, 2018, 28(21):3308-3311.
[6] 子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志, 2017, 52(12):793-800.
[7] 《抗菌药物临床应用指导原则》修订工作组. 抗菌药物临床应用指导原则:2015年版[M]. 北京:人民卫生出版社, 2015.
[8] OTAKE A, HORAI M, TANAKA E, et al. Influences of total laparoscopic hysterectomy according to body mass index (underweight, normal weight, overweight, or obese)[J]. Gynecol Mini Invasive Ther, 2019, 8(1): 19-23.
[9] HOUSMANS S, NOORI N, KAPURUBANDARA S, et al. Systematic review and Meta-analysis on hysterectomy by vaginal natural orifice transluminal endoscopic surgery (vNOTES) compared to laparoscopic hysterectomy for benign indications[J]. J Clin Med, 2020, 9(12): 3959-3962.
[10] SHEYN D, BRETSCHNIEDER C E, MAHAJAN S T, et al. Comparison of 30-day complication rates between laparoscopic myomectomy and total laparoscopic hysterectomy for the treatment of uterine leiomyoma in women older than age 40[J]. J Minim Invas Gyn, 2019, 26(6): 1076-1082.
[11] UCCELLA S, MALZONI M, CROMI A, et al. Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy[J]. Am J Obstet Gynecol, 2018, 218(5): 500-513.
[12] CHAO L, MANSURIA S. Postoperative bladder filling after outpatient laparoscopic hysterectomy and time to discharge: a randomized controlled trial[J]. Obstet Gynecol, 2019, 133(5): 879-887.
[13] JIN L, JI L, SHAO M, et al. Laparoscopic myomectomy with temporary bilateral uterine artery and utero-ovarian vessels occlusion compared with traditional surgery for uterine fibroids: Blood loss and recurrence[J]. Gynecol Obstet Inves, 2019, 84(6): 548-554.
[14] BAEKELANDT J F, de MULDER P A, LE ROY I, et al. Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy as a day-care procedure: a randomised controlled trial[J]. BJOG, 2019, 126(1): 105-113.
[15] ALA-NISSILÄ S, LAURIKAINEN E, MÄKINEN J, et al. Vaginal cuff dehiscence is observed in a higher rate after total laparoscopic hysterectomy compared with other types of hysterectomy[J]. Acta Oobstet Gyn Scan, 2019, 98(1): 44-50.
[16] ANNAN J J K, ASUBONTENG G O, KONNEY T O. Experience with diagnostic laparoscopy in the evaluation of tubal factor infertility[J]. Open J Obstet Gynecol, 2020, 10(05): 688-692.
[17] SHEYN D, EL-NASHAR S, BILLOW M, et al. Readmission rates after same-day discharge compared with postoperative day 1 discharge after benign laparoscopic hysterectomy[J]. J Minim Invas Gyn, 2018, 25(3): 484-490.
[18] TAKEDA A, KOIKE W, TSUGE S, et al. Pregnancy outcome after emergency uterine artery embolisation for management of intractable haemorrhage associated with laparoscopic-assisted myomectomy[J]. J Obstet Gynaecol, 2020, 40(8): 1111-1117.
[19] FATHY M, AL-AZONY H, HASANEN E, et al. Total laparoscopic hysterectomy versus total abdominal hysterectomy in uterine tumors[J]. Egy J Hosp Med, 2018, 72(10): 5427-5432.
[20] TEMTANAKITPAISAN A, TEMTANAKITPAISAN T. Laparoscopic myomectomy outcomes: an experience in Srinagarind Hospital[J]. Srinagarind Med J, 2019, 34(5): 422-426.